Table 2. Estimated costs and health outcomes for parasite control programs among Asian refugees, 27,700 annual cohort.
| No program | Overseas Albendazole and Ivermectin | Domestic Screening and Treatment | Overseas Albendazole and Domestic Screening for Strongyloides | |
|---|---|---|---|---|
| Costs, 2013 USD | ||||
| Total costs (27,700 refugees) | $165,923 | $418,824 | $3,832,572 | $2,182,483 |
| Component Costs: | ||||
| Program (27,700 refugees) | $0 | $386,969 | $3,788,252 | $2,138,163 |
| Health department for screening and treatment | $0 | $108,030 | $3,572,192 | $1,988,029 |
| Overseas presumptive treatment | $0 | $269,244 | $0 | $79,776 |
| Refugee opportunity (screening and treatment) | $0 | $9,695 | $216,060 | $70,358 |
| Illness (27,700 refugees) | $165,923 | $31,855 | $44,320 | $44,320 |
| Treatment (payments) | $139,885 | $26,869 | $37,395 | $37,395 |
| Treatment (opportunity) | $26,038 | $4,986 | $6,925 | $6,925 |
| Cost per refugee, 2013 USD: | ||||
| Total a | $5.99 | $15.12 | $138.36 | $78.79 |
| Program b | $0.00 | $13.97 | $136.76 | $77.19 |
| Illness c,d | $5.99 | $1.15 | $1.60 | $1.60 |
| Health outcomes (discounted): d | ||||
| Outpatient cases | 145 | 29 | 40 | 39 |
| Hospitalizations | 4.0 | 0.8 | 1.1 | 1.1 |
| Deaths | 0.67 | 0.13 | 0.18 | 0.18 |
| Life years | 700,526 | 700,536 | 700,535 | 700,535 |
| QALYs | 605,253 | 605,377 | 605,366 | 605,366 |
| Economic outcomes relative to “No Program” expressed in Net Costs Per Category: | ||||
| Case averted | 2,146 | 34,907 | 18,483 | |
| Hospitalization averted | 76,606 | 1,238,977 | 680,735 | |
| Death averted | 458,718 | 7,419,026 | 4,076,259 | |
| Life year gained | 24,036 | 388,754 | 213,594 | |
| QALY gained | 2,219 | 32,706 | 18,167 | |
| QALY gained, 95% credibility interval e | 600–29,500 | 6,000–168,000 | 3,300–89,000 | |
a Total cost per refugee is calculated from the total (program + illness) cost divided by the cohort size (n = 27,700). This total may not be equal to the sum of program cost per refugee + illness cost per refugee because of rounding differences.
b Program cost per refugee is calculated from the program cost divided by the cohort size (n = 27,700).
c Illness cost per refugee is calculated from the illness cost divided by the cohort size (n = 27,700).
d Cost and outcomes are discounted at 3% year over a 60-year period after arrival.
e These credibility intervals are based on 10,000 random parameter draws using Monte Carlo Simulation (See S1 Appendix for details).